Lv3
310 积分 2024-08-14 加入
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
10小时前
待确认
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study
10小时前
已完结
90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial
10小时前
已完结
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
11小时前
已完结
Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
11小时前
已完结
Surrogate End Points and Their Validation in Oncology Clinical Trials
11小时前
已完结
Antibody–drug conjugates for cancer
11小时前
已完结
Antibody–drug conjugates come of age in oncology
12小时前
已完结
Objective Response Rate and Progression-Free Survival as Surrogates for Overall Survival Treatment Effect: A Meta-analysis across Diverse Tumour Groups and Contemporary Therapies
1个月前
已完结
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis
3个月前
已完结
皖公网安备34019202002308
